Karen LaRochelle - Jan 29, 2024 Form 4 Insider Report for PaxMedica, Inc. (PXMD)

Role
Director
Signature
/s/ Stephen D. Sheldon, Jr. Attorney-in-Fact
Stock symbol
PXMD
Transactions as of
Jan 29, 2024
Transactions value $
-$37
Form type
4
Date filed
1/31/2024, 05:19 PM
Previous filing
Nov 29, 2023
Next filing
Mar 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PXMD Common Stock Sale -$37 -78 -2.68% $0.48 2.83K Jan 29, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to the Reporting Person's pre-existing Rule 10b5-1 trading plan to, inter alia, pay tax withholding on vested RSUs.
F2 The sale price represents the weighted average sale price of the shares sold ranging from $0.47 to $0.48 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.